- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging formats for next-generation antibody drug conjugates
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 10, Issue 5, Pages 463-481
Publisher
Informa Healthcare
Online
2015-03-23
DOI
10.1517/17460441.2015.1025049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural Products as Exquisitely Potent Cytotoxic Payloads for Antibody- Drug Conjugates
- (2015) Samantha Gromek et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Abstract 2665: Transforming Notch ligands into tumor-antigen targets: A Probody-Drug Conjugate (PDC) targeting Jagged 1 and Jagged 2
- (2015) Jason Sagert et al. CANCER RESEARCH
- Cysteine-Selective Reactions for Antibody Conjugation
- (2014) Pedro M. S. D. Cal et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Preparation of Well-Defined Antibody-Drug Conjugates through Glycan Remodeling and Strain-Promoted Azide-Alkyne Cycloadditions
- (2014) Xiuru Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Engineered Fc based antibody domains and fragments as novel scaffolds
- (2014) Tianlei Ying et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers
- (2014) James T. Patterson et al. BIOCONJUGATE CHEMISTRY
- Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
- (2014) George Badescu et al. BIOCONJUGATE CHEMISTRY
- Mild Method for Succinimide Hydrolysis on ADCs: Impact on ADC Potency, Stability, Exposure, and Efficacy
- (2014) L. Nathan Tumey et al. BIOCONJUGATE CHEMISTRY
- Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody–Drug Conjugates
- (2014) Patrick Dennler et al. BIOCONJUGATE CHEMISTRY
- Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System
- (2014) Erik S. Zimmerman et al. BIOCONJUGATE CHEMISTRY
- Site-Specific Antibody–Drug Conjugation through Glycoengineering
- (2014) Qun Zhou et al. BIOCONJUGATE CHEMISTRY
- Armed antibodies for cancer treatment: a promising tool in a changing era
- (2014) Riccardo Danielli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
- (2014) E. Perrino et al. CANCER RESEARCH
- A bioorthogonal 68Ga-labelling strategy for rapid in vivo imaging
- (2014) Helen L. Evans et al. CHEMICAL COMMUNICATIONS
- Exploring the effects of linker composition on site-specifically modified antibody–drug conjugates
- (2014) Aaron E. Albers et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Probody therapeutics for targeting antibodies to diseased tissue
- (2014) Krishna R Polu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Unnatural amino acids in novel antibody conjugates
- (2014) Trevor J Hallam et al. Future Medicinal Chemistry
- Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE(R)) antibody construct blinatumomab as a potential therapy
- (2014) Z. Zimmerman et al. INTERNATIONAL IMMUNOLOGY
- Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
- (2014) Nancy L Bartlett et al. Journal of Hematology & Oncology
- Antibody Engineering and Therapeutics
- (2014) Juan Carlos Almagro et al. mAbs
- HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design
- (2014) Bart ECG de Goeij et al. mAbs
- 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland
- (2014) Janice M Reichert et al. mAbs
- Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody-Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect
- (2014) S. Golfier et al. MOLECULAR CANCER THERAPEUTICS
- ANG4043, a Novel Brain-Penetrant Peptide-mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
- (2014) A. Regina et al. MOLECULAR CANCER THERAPEUTICS
- A Chemically Defined Trifunctional Antibody-Cytokine-Drug Conjugate with Potent Antitumor Activity
- (2014) T. List et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform
- (2014) W. Dokter et al. MOLECULAR CANCER THERAPEUTICS
- Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
- (2014) Robert P Lyon et al. NATURE BIOTECHNOLOGY
- Next-generation antibodies
- (2014) James B. Evans et al. NATURE REVIEWS DRUG DISCOVERY
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry
- (2014) Jianxin Guo et al. PHARMACEUTICAL RESEARCH
- A general approach to site-specific antibody drug conjugates
- (2014) Feng Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemically programmed antibodies
- (2014) Christoph Rader TRENDS IN BIOTECHNOLOGY
- Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
- (2014) J Diessner et al. Cell Death & Disease
- Genetic Incorporation of Multiple Unnatural Amino Acids into Proteins in Mammalian Cells
- (2013) Han Xiao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Orthogonal Assembly of a Designed Ankyrin Repeat Protein–Cytotoxin Conjugate with a Clickable Serum Albumin Module for Half-Life Extension
- (2013) Manuel Simon et al. BIOCONJUGATE CHEMISTRY
- Facile and Stabile Linkages through Tyrosine: Bioconjugation Strategies with the Tyrosine-Click Reaction
- (2013) Hitoshi Ban et al. BIOCONJUGATE CHEMISTRY
- A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
- (2013) Scott C. Jeffrey et al. BIOCONJUGATE CHEMISTRY
- Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates
- (2013) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Investigation into Temperature-Induced Aggregation of an Antibody Drug Conjugate
- (2013) Nia S. Beckley et al. BIOCONJUGATE CHEMISTRY
- Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer
- (2013) Manfred Welslau et al. CANCER
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Antibody–drug conjugates: current status and future directions
- (2013) Heidi L. Perez et al. DRUG DISCOVERY TODAY
- Brentuximab Vedotin: A Review of Its Use in Patients with Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma Following Previous Treatment Failure
- (2013) Karly P. Garnock-Jones DRUGS
- Advancing Antibody Drug Conjugation
- (2013) Nicole M. Okeley et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA
- (2013) Christine Klinguer-Hamour et al. mAbs
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Antibody-drug conjugates
- (2013) Alain Beck et al. mAbs
- Methods for site-specific drug conjugation to antibodies
- (2013) Christopher R Behrens et al. mAbs
- Antibody conjugation via one and two C-terminal selenocysteines
- (2013) Xiuling Li et al. METHODS
- The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics
- (2013) Hans-Peter Gerber et al. NATURAL PRODUCT REPORTS
- Antibody–drug conjugates
- (2013) Rachel S. Zolot et al. NATURE REVIEWS DRUG DISCOVERY
- A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma
- (2013) Larissa Sweeny et al. ORAL ONCOLOGY
- A Human Anti-c-Met Fab Fragment Conjugated with Doxorubicin as Targeted Chemotherapy for Hepatocellular Carcinoma
- (2013) Ximin Chen et al. PLoS One
- Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology
- (2013) Stanley A. Roberts et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Microbials for the production of monoclonal antibodies and antibody fragments
- (2013) Oliver Spadiut et al. TRENDS IN BIOTECHNOLOGY
- Characterization of the drug-to-antibody ratio distribution for antibody–drug conjugates in plasma/serum
- (2013) Keyang Xu et al. Bioanalysis
- Bioanalytical assay strategies for the development of antibody–drug conjugate biotherapeutics
- (2013) Surinder Kaur et al. Bioanalysis
- Risks and untoward toxicities of antibody-based immunoconjugates
- (2012) Dana Litvak-Greenfeld et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates
- (2012) Diego A. Gianolio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Proposed mechanism of off-target toxicity for antibody–drug conjugates driven by mannose receptor uptake
- (2012) Boris Gorovits et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery
- (2012) Giulio Casi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
- (2012) Gerhard Moldenhauer et al. JNCI-Journal of the National Cancer Institute
- Effect of Small-Molecule–Binding Affinity on Tumor Uptake In Vivo : A Systematic Study Using a Pretargeted Bispecific Antibody
- (2012) Kelly Davis Orcutt et al. MOLECULAR CANCER THERAPEUTICS
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- A Pictet-Spengler ligation for protein chemical modification
- (2012) P. Agarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept
- (2012) Thierry Wurch et al. TRENDS IN BIOTECHNOLOGY
- Spacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature
- (2012) Martina Steiner et al. Chemical Science
- A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
- (2011) Gonçalo J. L. Bernardes et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
- (2011) A Palumbo et al. BRITISH JOURNAL OF CANCER
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Human kappa light chain targeted Pseudomonas exotoxin A — identifying human antibodies and Fab fragments with favorable characteristics for antibody–drug conjugate development
- (2011) C. Kellner et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation Propensity
- (2011) Timothy M. Lauer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Analytical methods for physicochemical characterization of antibody drug conjugates
- (2011) Aditya Wakankar et al. mAbs
- Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity
- (2011) Y. Cao et al. MOLECULAR CANCER THERAPEUTICS
- Bispecific digoxigenin-binding antibodies for targeted payload delivery
- (2011) S. Metz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
- (2010) Teemu T. Junttila et al. BREAST CANCER RESEARCH AND TREATMENT
- Anti-CD30 diabody-drug conjugates with potent antitumor activity
- (2008) K. M. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index
- (2008) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation